Millions of young children get malaria. These two got it in 2010.
AP Photo/Schalk van Zuydam
There's a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
Critics have worried Purdue might use bankruptcy to avoid accountability.
AP Photo/Jessica Hill
While critics accuse companies facing lots of lawsuits of using bankruptcy as a sort of 'get of jail free card,' the reality of the legal procedure is more complicated.
Some biologics can cost up to a million dollars for a year’s worth.
Biologics, therapies made inside or of living cells, are a growing share of pharmaceutical sales. But the cost of these miracle treatments makes them unaffordable for many. New FDA guidance may help.
Greenhouse gas emissions from pharmaceutical companies need to be better monitored and regulated.
The first study to assess the carbon footprint of the pharmaceutical industry finds that it is far from green.
A ‘hard Brexit’ appears increasingly likely.
AP Photo/Kirsty Wigglesworth
American companies still face enormous uncertainty about how they'll be doing business in the UK and EU in the coming years, particularly as the April 12 Brexit deadline draws closer.
Canadian finance minister Bill Morneau announced funding for a new Canadian Drug Agency in the 2019 Federal Budget. Here he speaks at a press conference in Toronto, March 20, 2019.
THE CANADIAN PRESS/Cole Burston
A new agency and money for drugs for rare diseases are only very partial steps on the road towards what Canada really needs: a national pharmacare plan.
Purdue faces about 2,000 lawsuits related to the opioid crisis.
AP Photo/Toby Talbot
OxyContin maker Purdue has reportedly been mulling a bankruptcy filling, just as the first of around 2,000 lawsuits against it prepares to go to trial.
Policymakers and consumers are well aware of rising pharmaceuticals prices.
AP Photo/Elise Amendola
The Trump administration's proposal to lower drug prices focuses on discounts. A health policy scholar argues that the US could learn from Europe's system of measuring drug value and effectiveness.
The lack of transparency seems to be worse in certain disease areas, including diabetes and heart disease.
Clinical guidelines have a big impact on the care you receive and the drugs you're prescribed. But one in five doctors who write these guidelines have undisclosed ties to drug companies.
Jose Juan Nogueron/Shutterstock
Don't mix your statins with grapefruit, or leafy green vegetables with warfarin.
Thanks to their consumption of invertebrates, Melbourne platypus likely receive half the recommended human dose of anti-depressants every day.
Pharmaceuticals were found in every invertebrate sampled from six Melbourne streams - including a waterway in a national park.
An animal experiment in a laboratory of the pharmaceutical company “Chemie Gruenenthal,” which manufactured the drug Thalidomide, in West Germany in 1969. Thalidomide was prescribed by doctors as a mild sleeping pill and for relief of morning sickness but caused the miscarriage and birth of thousands of children with severe malformations globally.
A new book, 'The Thalidomide Catastrophe,' raises new questions about the conduct of corporations involved. It is the duty of governments to find out the answers.
Drug trials should include people with more than one disease.
Miniature biomanufacturing kits like this prototype could revolutionize the pharmaceutical industry.
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
Could issues like price manipulation and over-regulation be having an impact on the medicine supply chain?
The reliability of a new guideline for the management of chronic hepatitis C is questionable, given the financial conflicts of interest documented by its authors.
In the run up to the Global Hepatitis Summit 2018, new guidelines for the management of hepatitis C should come under scrutiny – for financial conflict of interest and quality of evidence.
Medical cannabis challenges scientific norms and the usual regulation of medicines.
It doesn’t look like a kidney, but this ‘kidney-on-a-chip’ is a breakthrough for new drug testing.
Researchers who've created a kidney-on-a-chip explain why these kinds of devices are an improvement over traditional ways to test new drugs.
Thousands of people are dying every year of opioid-related overdoses, in an epidemic that traces its roots to 1996 and the introduction of the prescription drug OxyContin. Here, prescription opioids are shown in Toronto during 2017.
THE CANADIAN PRESS/Graeme Roy
Prescription drugs are policed by industry and Health Canada has never prosecuted a drug company for illegally marketing a drug.
High-tech ways to scan nature’s own creations.
Pharmaceutical companies focus on small molecules they've devised – and can easily patent. But nature's already come up with many antibacterial compounds that drug designers could use to make medicines.